News

The planned expansion added a second freestanding 20,000 square feet building to the existing campus. The new $3.5 million facility houses SpectraCell’s clinical laboratory operations while the existing

The study is designed to evaluate IPI-504 as a monotherapy in patients with stage IIIb/IV non-small cell lung cancer (NSCLC) whose tumors have relapsed or become refractory to

Under the terms of the agreement, Merck Serono will provide Lpath up to $23 million of upfront payments and R&D funding to support Lpath’s completion of the Phase

The product will be marketed under store brand labels and is comparable to Wyeth consumer healthcare’s Advil PM tablets, 200/38mg, indicated as a pain reliever or nighttime sleep-aid.

The agreement provides Ultra Ultrasonik with the rights to sell in Turkey and includes minimum purchase requirements. The SonaStar is used by neuro and general surgeons for quick

The first new type of blood pressure medicine in over a decade Rasilez, known as Tekturna in the US, provides effective blood pressure lowering that lasts beyond 24

The two-arm, randomized, multi-dose, double-blind, placebo-controlled study included Rhinocort as the steroid comparator arm. A secondary efficacy endpoint of this study was the effect of MRX-4 on inflammatory

The collaboration facilitates interactions between physicians and scientists in both organizations to combine resources and expertise in disease intervention whilst providing flexibility to work in a variety of

Under the terms of the agreement, Allergan will pay Spectrum $41.5 million at closing and will make additional payments of up to $304 million based on the achievement